Pediatric refractory and super-refractory status epilepticus.

Area of Science:

• Pediatric Neurology
• Critical Care Medicine
• Epileptology

Background:

• Refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE) are life-threatening neurological emergencies in children.
• These conditions are characterized by prolonged seizures unresponsive to standard antiepileptic drug treatments.
• RSE and SRSE are associated with significant long-term neurological deficits and high mortality rates.

Purpose of the Study:

• To review and summarize current evidence on pediatric RSE and SRSE.
• To focus on epidemiology, causes, treatment strategies, and outcomes.
• To highlight challenges in managing these complex neurological conditions.

Main Methods:

• A narrative review of existing medical literature.
• Searches conducted using the MEDLINE database.

Main Results:

• RSE is defined by failure to respond to first- and second-line antiepileptic drugs; SRSE involves persistent or recurrent seizures despite anesthesia.
• Management is challenging due to unrecognized etiologies and limited therapeutic options, often relying on case series and expert opinions.
• Continuous anesthetic infusion is a common treatment, but optimal protocols are unclear; non-pharmacological therapies have low evidence levels.
• Patients face neurological and systemic complications from prolonged seizures, polypharmacy, and extended hospitalizations.

Conclusions:

• Pediatric RSE and SRSE are critical neurological emergencies with limited therapeutic avenues.
• There is a need for multi-national collaborative studies to assess the safety and efficacy of existing treatments.
• Such collaborative efforts are essential to potentially improve patient outcomes in RSE and SRSE.